Comparison of generic, biosimilar, and innovator products | Download Table
Biosimilars in the United States: Considerations for Oncology Advanced Practitioners. - Abstract - Europe PMC
Opportunities and Challenges in Biosimilar Development - BioProcess InternationalBioProcess International
Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey - GaBI Journal
Biosimilars: Not Simply Generics
The Biosimilar Revolution Is Just Beginning in the US - Analysis Group
Biosimilars: Not Simply Generics
Frontiers | Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
Biosimilars in Hematology: A Work in Progress
Comparison of biosimilar and generic drugs | Download Table
BIOSIMILAR DEVELOPMENT - Biosimilar Biological Products: Development & Applications
Learning About Biosimilars | Sagent Biosimilars
Biosimilar Development – An Overview - Trilogy Writing & Consulting GmbH
Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey - GaBI Journal
Generics & Biosimilars: Market Trend & Regulatory | Credevo Articles
Will "Biosimilar" Medications Reduce the Cost of Biologic Drugs? - Scientific American Blog Network
Biosimilars: Generic Biologics or Something Much More Complex? - Practical Dermatology
Introduction to Biosimilar Medicines
Science of Biosimilars | JCO Oncology Practice
Comparison of generic, biosimilar, and innovator products | Download Table
Regulatory Explainer: Everything You Need to Know About Biosimilars | RAPS
Biosimilar Development – An Overview - Trilogy Writing & Consulting GmbH
A Primer on Biosimilars: Immunologic Complexity and Clinical Opportunity (Transcript)
Biologics Are Natural Monopolies (Part 1): Why Biosimilars Do Not Create Effective Competition | Health Affairs
Naming of Biological Products
